At the completion of this activity, the participant will be able to:
1. Review aortic stenosis and indication for transcatheter aortic valve replacement (TAVR)
2. Identify TAVR and associated risks after receiving TAVR
3. Discuss current guideline antithrombotic recommendations for TAVR in patients without other indication for anticoagulation
4. Discuss most recent literature regarding antithrombotic therapy after TAVR
5. Indicate optimal antithrombotic treatment plans following TAVR

Session date: 
10/17/2023 - 12:00pm to 1:00pm EDT
Location: 
AGH Kent Room
2nd Floor South Tower - Magovern Conference Center
Zoom Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454 - Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or register to take this course.